Jul 2 |
MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday
|
Jul 1 |
Y-mAbs names Peter Pfreundschuh as CFO
|
Jul 1 |
Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer
|
Jun 10 |
With 43% stake, Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) seems to have captured institutional investors' interest
|
Jun 7 |
Y-mAbs Announces Preclinical GD2-SADA Data to be Presented at 2024 SNMMI Annual Meeting
|
Jun 5 |
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
|
Jun 1 |
Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
|
Jun 1 |
Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
|
May 9 |
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
|
May 9 |
Y-mAbs: There's A Ceiling Here Somewhere
|